Apelin, the natural ligand of the orphan seven-transmembrane receptor APJ, inhibits human immunodeficiency virus type 1 entry.
about
The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptorsNovel G-protein-coupled receptor genes expressed in the brain: continued discovery of important therapeutic targets.Chemokine receptors: emerging opportunities for new anti-HIV therapies.Small expression tags enhance bacterial expression of the first three transmembrane segments of the apelin receptor.The apelin receptor: physiology, pathology, cell signalling, and ligand modulation of a peptide-activated class A GPCR.Involvement of a Stat3 binding site in inflammation-induced enteric apelin expression.Pancreatitis activates pancreatic apelin-APJ axis in miceThe role of apelin in cardiovascular function and heart failure.The apelinergic system: a promising therapeutic target.Discovery of a novel small molecule agonist scaffold for the APJ receptor.Directed Molecular Evolution of an Engineered Gammaretroviral Envelope Protein with Dual Receptor Use Shows Stable Maintenance of Both Receptor Specificities.Inhibition of HIV-1 fusion with small interfering RNAs targeting the chemokine coreceptor CXCR4.A possible role for hypoxia-induced apelin expression in enteric cell proliferation.Apelin decreases myocardial injury and improves right ventricular function in monocrotaline-induced pulmonary hypertension.Apelin acts in the subfornical organ to influence neuronal excitability and cardiovascular function.Apelin-12 and its structural analog enhance antioxidant defense in experimental myocardial ischemia and reperfusion.High apelin levels could be used as a diagnostic marker in multiple myeloma: A comparative study.Apelinergic System Structure and Function.Patent highlights: December 2015-January 2016.
P2860
Q30486707-9B60D0E4-4393-41F2-918D-8AF8AB771EB4Q34837608-804CCD26-E6F5-466C-8422-2BBC3CD00A87Q35050395-525772E4-3F9E-43D8-BC0B-54CAAB1B3026Q35054352-739BAED8-8884-4AC9-BF07-2E5FD25B0FE4Q36973488-7ECD55D6-B6AD-4763-BCBA-76D00A452071Q36977036-ED411A12-E183-4D17-81B1-8C63BA298264Q37051499-ACEE26EA-9400-448F-BD13-88B4FB8D4119Q37201175-C895E0B3-E3E5-4313-BD87-DD28BD117320Q37720708-68D2B948-A1C3-40F2-AED6-4E567EDC3239Q38760395-CE9D5DDE-D9F4-4844-87E8-43E5C3BEDFB0Q38816595-B72A0618-EBC7-4061-A056-60A7925D3DF9Q39630283-0551309F-82FE-498C-8E99-BD5616A3476AQ39998306-5919256B-6AD0-455C-B3A3-0A185A0E14FCQ46061151-FACDAB5D-EA0E-433F-8600-E7A75B1B68F3Q46895113-7B5FDAE0-84C2-462C-964D-25E20CDB7FEFQ46923255-F7423414-8E50-4EEE-AAD4-0BF6833E4653Q51445423-42B35116-4C85-48CA-8753-E490555D752CQ53468087-C4A81841-F649-48A3-9078-80C890FD5EE5Q54096626-6202E91F-8F0F-42BF-B24E-79028DE917AA
P2860
Apelin, the natural ligand of the orphan seven-transmembrane receptor APJ, inhibits human immunodeficiency virus type 1 entry.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Apelin, the natural ligand of ...... deficiency virus type 1 entry.
@ast
Apelin, the natural ligand of ...... deficiency virus type 1 entry.
@en
type
label
Apelin, the natural ligand of ...... deficiency virus type 1 entry.
@ast
Apelin, the natural ligand of ...... deficiency virus type 1 entry.
@en
prefLabel
Apelin, the natural ligand of ...... deficiency virus type 1 entry.
@ast
Apelin, the natural ligand of ...... deficiency virus type 1 entry.
@en
P2093
P2860
P1433
P1476
Apelin, the natural ligand of ...... odeficiency virus type 1 entry
@en
P2093
G Pollakis
J Goudsmit
M Cayabyab
O Nishimura
S Fukusumi
P2860
P304
11972-11976
P356
10.1128/JVI.74.24.11972-11976.2000
P577
2000-12-01T00:00:00Z